Clinical Trial Update: Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a targeted GEMOX therapy with ctDNA monitoring in patients with resectable gallbladder cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gallbladder Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Gallbladder Carcinoma | Phase 2 | Status: RECRUITING